Skip to Content

CD 129 (Ranitidine Hydrochloride 150 mg)

Pill with imprint CD 129 is Brown, Capsule-shape and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Dr. Reddy’s Laboratories Inc..

Ranitidine is used in the treatment of duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis; cutaneous mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CD 129

Ranitidine hydrochloride 150 mg CD 129 Front
Ranitidine hydrochloride 150 mg CD 129 Back
Ranitidine hydrochloride 150 mg CD 129
Ranitidine hydrochloride 150 mg CD 129

Ranitidine Hydrochloride

Imprint:
CD 129
Strength:
150 mg
Color:
Brown
Size:
15.00 mm
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Dr. Reddy’s Laboratories Inc.
Inactive Ingredients:

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
55111-0129 Dr. Reddy's Laboratories, Inc.
42291-0735 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide